findmyKOL

Kelan Tantisira, MD, MPH

Enriched profile

Chief, Division of Respiratory Medicine, Rady Children's Hospital-San Diego; Professor of Pediatrics, UC San Diego School of Medicine · University of California, San Diego

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyPulmonary DiseaseFocusAsthma and respiratory diseases+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding2021–2026

Kelan Tantisira is Chief, Division of Respiratory Medicine, Rady Children's Hospital-San Diego; Professor of Pediatrics, UC San Diego School of Medicine at University of California, San Diego. OpenAlex indexes 350 publications with 13,851 citations (h-index 61); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 10 Oct 2026

Overview

Updated 15 Oct 2026

Kelan Tantisira, MD MPH, is Chief, Division of Respiratory Medicine, Rady Children's Hospital-San Diego at University of California, San Diego. The public record shows 350 publications with 13,851 citations (h-index 61), centered on Asthma and respiratory diseases, Genetic Associations and Epidemiology, Chronic Obstructive Pulmonary Disease (COPD) Research. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies, 2 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Asthma and respiratory diseases
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Asthma1 trialCOPD

Research focus

OpenAlex concept fingerprint
Asthma and respiratory diseasesGenetic Associations and EpidemiologyChronic Obstructive Pulmonary Disease (COPD) ResearchMicroRNA in disease regulationPharmacogenetics and Drug Metabolism

Drugs & molecules

across trials, industry payments and publications
Xembifygeneric · Immunoglobulin GClinical trials—Industry payments2Publications—NEFFYClinical trials—Industry payments1Publications—Nucalageneric · MepolizumabClinical trials—Industry payments1Publications—PalforziaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca UK LimitedClinical trials—Industry payments8AstraZeneca ABClinical trials—Industry payments2Grifols USA, LLCClinical trials—Industry payments2ARS Pharmaceuticals Operations, Inc.Clinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1Greer Laboratories, Inc.Clinical trials—Industry payments1University of California, San DiegoClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
350publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

13,851citations

Total citations across indexed works.

61h-index

Hirsch index (OpenAlex). i10-index 175.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 15 Oct 2026

2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Scott T. Weiss218Michael J. McGeachie87Alvin T. Kho82Jessica Ann Lasky-Su56Augusto A. Litonjua47Juan Carlos Celedon40Ann Chen Wu39Benjamin A. Raby33Amber Dahlin32Barbara J. Klanderman31Edwin K. Silverman30Dawn Lisa DeMeo30Blanca E. Himes28Rinku Sharma28Weiliang Qiu28Stephen P. Peters27Alberta L. Wang22Sunita Sharma22John J. Lima22Joanne E. Sordillo21Roger Gaedigk21Jiang Li21Jarrett D. Morrow19Ross M Lazarus19Priyadarshini Kachroo19Rachel S. Kelly19Charles G. Irvin18Quan Lu18Anshul Tiwari17Carrie A. Vyhlidal15Gerard H. Koppelman15Qing Duan15Stanley James Szefler15Sharon Marie Lutz15Mayumi Tamari14Eugene R. Bleecker14Kimberly Glass14Vincent J. Carey14Anke H. Maitland‐van der Zee13Elliot Israel13

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.